{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:11:51Z","timestamp":1698736311094},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T00:00:00Z","timestamp":1348444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Antitumor necrosis factor (anti\u2010TNF) agents are a well\u2010established treatment for various medical conditions, including psoriasis and psoriatic arthritis. However, anti\u2010TNF agents may themselves induce psoriasis in some patients.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> The authors report two cases of patients with severe and refractory infliximab\u2010induced psoriasis.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> The patients had good clinical responses after switching to another TNF blocker.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> For severe cases, infliximab withdrawal combined with conventional immunosuppressive psoriasis drugs or with adalimumab may be a therapeutic option.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2012.05601.x","type":"journal-article","created":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T08:37:06Z","timestamp":1348475826000},"page":"234-238","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Severe infliximab\u2010induced psoriasis treated with adalimumab switching"],"prefix":"10.1111","volume":"52","author":[{"given":"C\u00e9sar","family":"Faillace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gleison Vieira","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ros\u00e2ngela Santos","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joz\u00e9lio Freire","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq169"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2008.01639.x"},{"key":"e_1_2_5_4_2","first-page":"546","article-title":"Anti\u2010TNF agents for the treatment of psoriasis","volume":"8","author":"Kircik LH","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.12.9.1085"},{"key":"e_1_2_5_6_2","first-page":"178","article-title":"Infliximab\u2010associated new\u2010onset psoriasis","volume":"5","author":"Adams DR","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.9.829"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06107.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1724"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.12.1627"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20954"},{"key":"e_1_2_5_12_2","first-page":"405","article-title":"Unexpected new onset or exacerbating of psoriasis in treatment of active ankylosing spondylitis with TNF\u2010alpha blocking agents","volume":"63","author":"Haibel H","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.037424"},{"key":"e_1_2_5_14_2","first-page":"276","article-title":"New onset of aggravating of psoriatic skin lesions in patients with definitive rheumatoid arthritis under treatment with TNF\u2010alpha antagonists: report of 8 cases [abstract]","volume":"63","author":"Kary S","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06977.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2005.01882.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21233"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-004-0567-5"},{"key":"e_1_2_5_19_2","first-page":"439","article-title":"Pustular psoriasis induced by infliximab","volume":"3","author":"Thurber M","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23835"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087288"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181f3d9ab"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.11.001"},{"key":"e_1_2_5_24_2","article-title":"Resolution of adalimumab\u2010induced psoriasis after vitamin D deficiency treatment","author":"Werner de Castro GR","year":"2011","journal-title":"Rheumatol Int"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20954"},{"key":"e_1_2_5_26_2","unstructured":"ChusteckaZ.Psoriasis with TNF inhibitors: is there an infectious etiology?http:\/\/www.jointandbone.org\/viewArticle.do?primaryKey=569511[Accessed 6 October 2005]."},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/514618"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.12.1490"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.2.223"},{"key":"e_1_2_5_30_2","first-page":"107","article-title":"Switching between TNFalpha antagonists in rheumatoid arthritis: personal experience and review of the literature","volume":"61","author":"Scrivo R","year":"2009","journal-title":"Reumatismo"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.054742"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2012.05601.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2012.05601.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T05:26:53Z","timestamp":1698643613000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2012.05601.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,24]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1111\/j.1365-4632.2012.05601.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2012.05601.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,24]]},"assertion":[{"value":"2012-09-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}